Support this station KPLU 88.5 - NPR News and All that Jazz
News for Seattle and the Northwest
Last updated 2:58AM ET
May 26, 2012
KPLU Local News
KPLU Local News
Money Matters: Cell Therapeutics
Greg Heberlein & Dave Meyer (2010-02-16)
Photo courtesy CTI
SEATTLE, WA (KPLU) - Biotech stocks can be risky. Seattle-based Cell Therapeutics was very popular with investors ten years ago but may be running out of time and money. Greg Heberlein talks about the company with KPLU's Dave Meyer on this week's Money Matters. © Copyright 2012, KPLU